Results 21 to 30 of about 9,281 (210)

NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand

, 2021
BACKGROUND: We studied the prevalence of neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) in Indigenous populations of Australia and New Zealand with the aim of assessing potential differences.
Fabis-Pedrini, Marzena, Mason, Deborah F, Bukhari, Wajih, Khalilidehkordi, Elham, Taylor, Bruce V, Australian and New Zealand NMO Collaboration, Barnett, Michael H, Subramanian, Sankar, Broadley, Simon A, Waters, Patrick, Kermode, Allan G, Russell C. Dale, Celia Chen, John King, Pamela A. McCombe, Angela Vincent, Ernest Willoughby, Chris Kneebone, Mark P. Marriott, Richard A. L. Macdonell, Michael P. Pender, Stefan Blum, Kerri M. Prain, Chandi Das, John D. E. Parratt, Marzena Fabis-Pedrini, Christine S. Bundell, Stephen W. Reddell, Patrick Waters, Laura Clarke, Richard C. Wong, Deborah F. Mason, Robert Heard, Mark Woodhall, David Fulcher, Andrew J. Kornberg, Wallace J. Brownlee, Keith Dear, Allan G. Kermode, Suzanne Hodgkinson, Sofia Jimenez Sanchez, Cullen O’Gorman, Judith Spies, Karyn Boundy, Trevor J. Kilpatrick, Simon A. Broadley, null null, Wajih Bukhari, Sandeep Bhuta, Simon Hawke, Michael H. Barnett, Ian Sutton, Michael Walsh, Jeannette Lechner-Scott, Jennifer Pereira, John D. Pollard, Mark Slee, Bruce J. Brew, Alan Coulthard, Elham Khalilidehkordi, Steve Vucic, Saman Heshmat, William M. Carroll, Cameron Shaw, David Gillis, Sankar Subramanian, Mike Boggild, Fabienne Brilot, Ming-Wei Lin, Bruce V. Taylor, Sudarshini Ramanathan, James Stankovich, Chistopher Lynch, David Abernethy, Helmut Butzkueven, Roger A. Silvestrini, Eppie M. Yiu, Andrew P. D. Henderson   +77 more
core   +3 more sources

Macular vessel density differs in multiple sclerosis and neuromyelitis optica spectrum disorder: An optical coherence tomography angiography study.

PLoS ONE, 2021
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are inflammatory and demyelinating diseases that commonly manifest with optic neuritis (ON) but differ in the pathogenic mechanism.
Małgorzata Rogaczewska, Sławomir Michalak, Marcin Stopa   +2 more
doaj   +1 more source

Relatively Early and Late-Onset Neuromyelitis Optica Spectrum Disorder in Central China: Clinical Characteristics and Prognostic Features

Frontiers in Neurology, 2022
BackgroundWe aimed to analyze the clinical characteristics and prognostic features of Chinese patients with relatively late-onset neuromyelitis optica spectrum disorder (RLO-NMOSD>40 years of age at disease onset), compared with patients with ...
Jinbei Yu, Shuai Yan, Pengpeng Niu, Junfang Teng   +3 more
doaj   +1 more source

Contemporary management challenges in seropositive NMOSD

Journal of Neurology, 2022
Neuromyelitis optica spectrum disorders (NMOSD) is an inflammatory disorder of the central nervous system that presents unique management challenges. Neurologic disability in NMOSD is directly linked to acute attacks, therefore, relapse prevention is an overarching goal of care.
Costello, Fiona, Burton, Jodie M.
openaire   +2 more sources

Time to disability milestones and annualized relapse rates in NMOSD and MOGAD [PDF]

, 2023
OBJECTIVE: To investigate accumulation of disability in neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein-antibody-associated disease (MOGAD) in a changing treatment landscape.
Ringelstein, M., Kaste, M., Häußler, V., Paul, F., Bergh, F.T., Dawin, E., Walter, A., Grothe, M., Kleiter, I., Schindler, P., Senel, M., Hümmert, M.W., Krumbholz, M., Fischer, K., Duchow, A., Bellmann-Strobl, J., Friede, T., Stellmann, J.P., Giglhuber, K., Vardakas, I., Ayzenberg, I., Engels, D., Trebst, C., Tkachenko, D., Berthele, A., Schwake, C., Kümpfel, T., Weber, M.S., Wickel, J., Wildemann, B., Havla, J., Warnke, C., Schubert, C., Aktas, O., Kern, P., Kraemer, M., Lohmann, L., Rommer, P., Tumami, H., Angstwurm, K., Jarius, S., Klotz, L., Korporal-Kuhnke, M., Winkelmann, A., Flaskamp, M.   +44 more
core   +3 more sources

Plasma exchange as a first line therapy in acute attacks of neuromyelitis optica spectrum disorders

Annals of Indian Academy of Neurology, 2019
Background and Aims: Neuromyelitis optica spectrum disorder (NMOSD) is a demyelinating disorder of central nervous system with deleterious effects. At present Intravenous corticosteroids are used for the relapse as the first line of treatment, but with ...
B L Kumawat, Reenu Choudhary, C M Sharma, Deepak Jain, Ashwini Hiremath   +4 more
doaj   +1 more source

Neuromyelitis optica spectrum disorder

Advances in Clinical Neuroscience & Rehabilitation, 2017
Over the past 13 years neuromyelitis optica spectrum disorder (NMOSD) has emerged as a discrete form of demyelinating disease of the central nervous system in which antibodies against a water channel found in high concentration on astrocytes are ...
Simon Broadley, Elham Khalili, Saman Heshmat, Laura Clarke   +3 more
doaj   +1 more source

Significant up-regulation of lncRNAs in neuromyelitis optica spectrum disorder

Scientific Reports, 2023
Neuromyelitis optica spectrum disorder (NMOSD) is an immune-related demyelinating defect. Long non-coding RNAs (lncRNAs) might influence the pathobiology and progression of NMOSD.
Mohammad Taheri, Ahmad Sadeghi, Alireza Gharebaghi, Masoud Ghiasian, Solat Eslami, Sheyda Khalilian, Arezou Sayad, Soudeh Ghafouri-Fard   +7 more
doaj   +1 more source

Epidemiology of Pediatric NMOSD in Germany and Austria [PDF]

Frontiers in Neurology, 2020
Background: Neuromyelitis optica spectrum disorders (NMOSD) are severe inflammatory demyelinating disorders of the central nervous system mainly characterized by recurrent episodes of uni- or bilateral optic neuritis (ON), transverse myelitis (TM) and brainstem syndromes (BS).
Christian Lechner, Markus Breu, Eva-Maria Wendel, Barbara Kornek, Kathrin Schanda, Matthias Baumann, Markus Reindl, Kevin Rostásy   +7 more
openaire   +3 more sources

original data of NMOSD patients

, 2022
original data of NMOSD ...
Yacen Hu (9988460)
core   +1 more source